Free Access
Med Sci (Paris)
Volume 20, Number 4, Avril 2004
Page(s) 431 - 436
Section M/S revues
Published online 15 April 2004
  1. Launoy G, Grosclaude P, Pienkowski P, et al. Cancers digestifs en France. Comparaison de l’incidence dans 7 départements et estimation de l’incidence pour la France entière. Gastroenterol Clin Biol 1992; 16 : 633–8. [Google Scholar]
  2. Osler W, Mc Crae T. Cancer of the stomach. Philadelphia : Blakiston’s son and Co, 1900 : 157 p. [Google Scholar]
  3. Parsonnet J. When heredity is infectious. Gastroenterology 2000; 118 : 222–7. [Google Scholar]
  4. Malaty HM, El-Kasabany A, Graham D, et al. Age at acquisition of Helicobacter pylori infection : a follow-up study from infancy to adulthood. Lancet 2002; 359 : 931–5. [Google Scholar]
  5. Gasbarrini G, Pretolani S, Bonvicini F, et al. A population-based study of Helicobacter pylori infection in a european country : the San Marino study. Relation with gastrointestinal diseases. Gut 1995; 36 : 838–44. [Google Scholar]
  6. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2 : 28–37. [Google Scholar]
  7. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric cancer. N Engl J Med 1991; 325 : 1127–31. [Google Scholar]
  8. Helicobacter and cancer cooperative group. Gastric cancer and Helicobacter pylori : a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49 : 347–53. [Google Scholar]
  9. International agency for research of cancer (IARC). Infection with Helicobacter pylori. Monographs on the evaluation of carcinogenic risks to humans, vol. 61. Lyon : IARC, 1994 : 177–240. [Google Scholar]
  10. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and development of gastric cancer. N Engl J Med 2001; 345 : 784–9. [Google Scholar]
  11. Correa P. Human gastric carcinogenesis : a multistep and multifactorial process. First american cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52 : 6735–40. [Google Scholar]
  12. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40 : 297–301. [Google Scholar]
  13. Labenz J, Malfertheiner P. Helicobacter pylori in gastro-oesophageal reflux disease : causal agent, independent or protective factor ? Gut 1997; 41 : 277–80. [Google Scholar]
  14. Van der Hulst RWM, Van der Ende A, Dekker FW, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA : a prospective one-year follow-up study. Gastroenterology 1997; 40 : 297–301. [Google Scholar]
  15. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens : antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996; 91 : 1785–8. [Google Scholar]
  16. Israel DA, Salama N, Arnold CN, et al. Helocobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 2001; 107 : 611–20. [Google Scholar]
  17. Chiou GC, Chan CC, Sheu DL, et al. Helicobacter pylori infection induced alteration of gene expression in human gastric cells. Gut 2001; 48 : 598–604. [Google Scholar]
  18. Galmiche A, Rassow J, Doye A, et al. The N-terminal 34 kDa fragments of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrom C release. EMBO J 2000; 68 : 6361–70. [Google Scholar]
  19. Suganuma M, Kurusu M, Okabe S, et al. Helicobacter pylori membrane protein 1 : a new carcinogenic factor of Helicobacter pylori. Cancer Res 2001; 61 : 6356–9. [Google Scholar]
  20. Hansson LE, Nyrén O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335 : 242–9. [Google Scholar]
  21. Peek RM, Wirth HP, Moss SF, et al. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 2000; 118 : 48–59. [Google Scholar]
  22. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118 : 36–47. [Google Scholar]
  23. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer : overview and guidelines for management. J Med Genet 1999; 36 : 873–80. [Google Scholar]
  24. Brenner H, Bode G, Boeing H. Helicobacter pylori among offspring of patients with stomach cancer. Gastroenterology 2000; 118 : 31–5. [Google Scholar]
  25. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients : critical role of H. pylori. Gastroenterology 2000; 118 : 22–30. [Google Scholar]
  26. El-Omar EM, Carrington M, Chow WH. IL1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404 : 398–402. [Google Scholar]
  27. El-Omar EM. The importance of interleukin 1béta in Helicobacter pylori associated disease. Gut 2001; 48 : 743–47. [Google Scholar]
  28. Machado JC, Pharoah P, Sousa S, et al. Interleukin-1béta and interleukin-1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121 : 823–29. [Google Scholar]
  29. Hwang I, Kodama T, Kikuchi S, et al. Effect of interleukin-1 polymorphisms on gastric acid mucosal interleukin-1béta production in Helicobacter pylori infection. Gastroenterology 2002; 123 : 1793–803. [Google Scholar]
  30. Fox JG, Beck P, Dangler CA, et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat Med 2000; 6 : 536–42. [Google Scholar]
  31. Park WS, Oh RR, Park JY, et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 2000; 119 : 691–8. [Google Scholar]
  32. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers 1997; 6 : 639–42. [Google Scholar]
  33. Parsonnet J, Harris RA, Hack HM, Owens DK. Modeling cost effectiveness of Helicobacter pylori sreening to prevent gastric cancer : a mandate for clinical trials. Lancet 1996; 348 : 150–4. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.